Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 3/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | RARB | P10826 | 4/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | PPARA | Q07869 | 1/20 | 0.51 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL495530 | 0.98 | HTT (0.63) | ALDH1A1L3MBTL1HTTTP53TSHR | |
| SCHEMBL27894195 | 0.98 | HTT (0.63) | ALDH1A1L3MBTL1HTTTP53TSHR | |
| Hydrochloric Acid SCHEMBL7084259 | 0.97 | HTT (0.62) | ALDH1A1L3MBTL1HTTTP53TSHR | |
| Hydroquinone SCHEMBL827468 | 0.94 | ALDH1A1 (0.58) | ALDH1A1L3MBTL1HTTTP53TSHR | |
| SCHEMBL27853261 | 0.85 | ALDH1A1 (0.51) | ALDH1A1L3MBTL1HTTTP53TSHR | |
| SCHEMBL13183005 | 0.85 | HDAC1 (0.61) | PPARA | |
| SCHEMBL827467 | 0.85 | LMNA (0.51) | ALDH1A1L3MBTL1HTTTSHRPOLB | |
| SCHEMBL29061539 | 0.84 | HDAC1 (0.64) | PPARA | |
| SCHEMBL5960563 | 0.84 | HTT (0.60) | ALDH1A1L3MBTL1HTTTP53TSHR | |
| SCHEMBL1952122 | 0.83 | TP53 (0.79) | ALDH1A1L3MBTL1HTTTP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101087864-B | Cholesteric monolayers and monolayer pigments with particular properties, their production and use | SICPA HOLDING SA | 2014-11-26 | — | — | CN | disclosed |
| EP-2143710-B1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICALLY ANISOTROPIC MATERIAL | ZEON CORP (JP) | 2014-07-09 | — | — | EP | disclosed |
| US-8158021-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optical anisotropic article | ZEON CORPORATION (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20100258764-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICAL ANISOTROPIC ARTICLE | ZEON CORPORATION (JP) | 2010-10-14 | — | — | US | disclosed |
| EP-2143710-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICALLY ANISOTROPIC MATERIAL | ZEON CORPORATION (JP) | 2010-01-13 | — | — | EP | disclosed |
| US-7396486-B2 | Polymerizable mixtures | WACKER CHEMIE AG (DE) | 2008-07-08 | — | — | US | disclosed |
| CN-101087864-A | Cholesteric monolayers and monolayer pigments with particular properties, their production and use | SICPA HOLDING SA (CH) | 2007-12-12 | — | — | CN | disclosed |
| EP-1831328-A1 | CHOLESTERIC MONOLAYERS AND MONOLAYER PIGMENTS WITH PARTICULAR PROPERTIES, THEIR PRODUCTION AND USE | Sicpa Holding S.A. (CH) | 2007-09-12 | — | — | EP | disclosed |
| CN-1302089-C | Polymerisable mixtures | CONSORTIUM ELEKTROCHEM IND (DE) | 2007-02-28 | — | — | CN | disclosed |
| WO-2006063926-A1 | CHOLESTERIC MONOLAYERS AND MONOLAYER PIGMENTS WITH PARTICULAR PROPERTIES, THEIR PRODUCTION AND USE | SICPA HOLDING S.A. (CH) | 2006-06-22 | — | — | WO | disclosed |
| US-20060097224-A1 | Polymerisable mixtures | WACKER CHEMIE AG (DE) | 2006-05-11 | — | — | US | disclosed |
| CN-1711335-A | Polymerisable mixtures | CONSORTIUM ELEKTROCHEM IND (DE) | 2005-12-21 | — | — | CN | disclosed |
| US-6486338-B1 | Preparation of organosilicon compounds containing α, β-unsaturated carboxylic acids | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2002-11-26 | — | — | US | disclosed |
| US-6423246-B1 | LIQUID CRYSTAL POLYMERS AND CROSSLINKING | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2002-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100258764-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICAL ANISOTROPIC ARTICLE | LEO1, ZYX, CCNT1 | ALDH1A1 2720/4885L3MBTL1 248/4885HTT 4719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.